KATHERINE CAGGIANO: Open Payments
NPI 1689746323 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 16 payments from 9 companies in 2025. Trend: 2023 $339 · 2024 $436 · 2025 $441
Food & beverage: $366Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $174 |
| Janssen Biotech, Inc. | 1 | $75 |
| UCB, Inc. | 1 | $47 |
| Galderma Laboratories, L.P. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
Products named: SKYRIZI, TREMFYA, RINVOQ, Bimzelx, NEMLUVIO, Sotyktu, Zoryve, SOFDRA.
Industry payments across NC — which companies pay providers there.
